153 related articles for article (PubMed ID: 35137463)
1. Mixed gangliocytoma-pituitary adenoma in MEN1 syndrome: A case report and literature review.
Martin EC; Bitner BF; Perez-Rosendahl M; Kuan EC; Linskey ME
Neuropathology; 2022 Apr; 42(2):155-159. PubMed ID: 35137463
[TBL] [Abstract][Full Text] [Related]
2. Transdifferentiation of Neuroendocrine Cells: Gangliocytoma Associated With Two Pituitary Adenomas of Different Lineage in MEN1.
Sergeant C; Jublanc C; Leclercq D; Boch AL; Bielle F; Raverot G; Daly AF; Trouillas J; Villa C
Am J Surg Pathol; 2017 Jun; 41(6):849-853. PubMed ID: 28079577
[TBL] [Abstract][Full Text] [Related]
3. Frequency of multiple endocrine neoplasia type 1 in a group of patients with pituitary adenoma: genetic study and familial screening.
Nunes VS; Souza GL; Perone D; Conde SJ; Nogueira CR
Pituitary; 2014 Feb; 17(1):30-7. PubMed ID: 23334809
[TBL] [Abstract][Full Text] [Related]
4. Unique gene expression profile associated with an early-onset multiple endocrine neoplasia (MEN1)-associated pituitary adenoma.
Farrell WE; Azevedo MF; Batista DL; Smith A; Bourdeau I; Horvath A; Boguszewski M; Quezado M; Stratakis CA
J Clin Endocrinol Metab; 2011 Nov; 96(11):E1905-14. PubMed ID: 21917868
[TBL] [Abstract][Full Text] [Related]
5. [Multiple Endocrine Neoplasia I (Wermers Syndrome), Forms of Clinical Manifestation, 5 Case Studies].
Drbalová K; Herdová K; Krejčí P; Nývltová M; Solař S; Vedralová L; Záruba P; Netuka D; Bavor P
Vnitr Lek; 2016; 62(9 Suppl 3):140-149. PubMed ID: 27734708
[TBL] [Abstract][Full Text] [Related]
6. Pituitary adenomas in the setting of multiple endocrine neoplasia type 1: a single-institution experience.
Cohen-Cohen S; Brown DA; Himes BT; Wheeler LP; Ruff MW; Major BT; Singh Ospina NM; Atkinson JLD; Meyer FB; Bancos I; Young WF; Van Gompel JJ
J Neurosurg; 2020 Apr; 134(3):1132-1138. PubMed ID: 32244213
[TBL] [Abstract][Full Text] [Related]
7. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A;
Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 in Poland: a two-centre experience.
Soczomski P; Jurecka-Lubieniecka B; Rogozik N; Tukiendorf A; Jarząb B; Bednarczuk T
Endokrynol Pol; 2019; 70(5):385-391. PubMed ID: 31274185
[TBL] [Abstract][Full Text] [Related]
9. Clinical and molecular features of four Brazilian families with multiple endocrine neoplasia type 1.
Miranda ISM; Valadares LP; Barra GB; Mesquita PG; de Santana LB; de Castro LF; Rita THS; Naves LA
Front Endocrinol (Lausanne); 2023; 14():1117873. PubMed ID: 36967793
[TBL] [Abstract][Full Text] [Related]
10. Absence of germ-line mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in familial pituitary adenoma in contrast to MEN1 in Japanese.
Tanaka C; Yoshimoto K; Yamada S; Nishioka H; Ii S; Moritani M; Yamaoka T; Itakura M
J Clin Endocrinol Metab; 1998 Mar; 83(3):960-5. PubMed ID: 9506756
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in MEN1 gene study for pituitary tumor pathogenesis.
Kameya T; Tsukada T; Yamaguchi K
Front Horm Res; 2004; 32():265-91. PubMed ID: 15281352
[TBL] [Abstract][Full Text] [Related]
12. Mixed gangliocytoma-pituitary adenoma in the sellar region: a large-scale single-center experience.
Yang B; Yang C; Sun Y; Du J; Liu P; Jia G; Jia W; Zhang Y; Wang J; Xu Y; Wang S
Acta Neurochir (Wien); 2018 Oct; 160(10):1989-1999. PubMed ID: 30109498
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic Endonasal Resection of a Mixed Lesion of Gangliocytoma and Nonfunctioning Pituitary Adenoma.
Heng LJ; Jia D; Gong L; Zhang W; Ma J; Qu Y
World Neurosurg; 2017 Oct; 106():1050.e1-1050.e6. PubMed ID: 28532920
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the MEN1 tumor suppressor gene in pituitary tumors.
Zhuang Z; Ezzat SZ; Vortmeyer AO; Weil R; Oldfield EH; Park WS; Pack S; Huang S; Agarwal SK; Guru SC; Manickam P; Debelenko LV; Kester MB; Olufemi SE; Heppner C; Crabtree JS; Burns AL; Spiegel AM; Marx SJ; Chandrasekharappa SC; Collins FS; Emmert-Buck MR; Liotta LA; Asa SL; Lubensky IA
Cancer Res; 1997 Dec; 57(24):5446-51. PubMed ID: 9407947
[TBL] [Abstract][Full Text] [Related]
15. Sporadic pituitary adenoma with somatic double-hit loss of MEN1.
Hong CS; Alanya H; DiStasio M; Boulware SD; Rimmer RA; Omay SB; Erson-Omay EZ
Pituitary; 2023 Aug; 26(4):488-494. PubMed ID: 37438451
[TBL] [Abstract][Full Text] [Related]
16. Mixed pituitary adenoma and gangliocytoma associated with acromegaly--case report.
Asada H; Otani M; Furuhata S; Inoue H; Toya S; Ogawa Y
Neurol Med Chir (Tokyo); 1990 Aug; 30(8):628-32. PubMed ID: 1703643
[TBL] [Abstract][Full Text] [Related]
17. Bilateral pituitary adenomas occurring with multiple endocrine neoplasia type one.
Sahdev A; Jäger R
AJNR Am J Neuroradiol; 2000; 21(6):1067-9. PubMed ID: 10871015
[TBL] [Abstract][Full Text] [Related]
18. Thymoma in multiple endocrine neoplasia type 1: a case report and systematic review.
Gao Y; Li R; Wu L; Yang H; Mao J; Zhao W
Endocrine; 2023 Nov; 82(2):442-449. PubMed ID: 37668926
[TBL] [Abstract][Full Text] [Related]
19. Analysis of loss of heterozygosity on chromosome 11 and infrequent inactivation of the MEN1 gene in sporadic pituitary adenomas.
Tanaka C; Kimura T; Yang P; Moritani M; Yamaoka T; Yamada S; Sano T; Yoshimoto K; Itakura M
J Clin Endocrinol Metab; 1998 Aug; 83(8):2631-4. PubMed ID: 9709923
[TBL] [Abstract][Full Text] [Related]
20. Increased menin expression in sporadic pituitary adenomas.
Wrocklage C; Gold H; Hackl W; Buchfelder M; Fahlbusch R; Paulus W
Clin Endocrinol (Oxf); 2002 May; 56(5):589-94. PubMed ID: 12030908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
